Lupin informs about press release

25 Aug 2022 Evaluate
Lupin has informed that it enclosed a Press Release as regards the Company having entered into an exclusive licensing agreement with l'rom Group Co, a leading pharmaceutical company in Japan for Denosumab bioslmilar for Japan.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2151.05 19.25 (0.90%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×